M

Microviable Therapeutics SL

13 employees

Microviable Therapeutics develops microbiota ecosystem products and microbiome therapies to improve human health.

Basic info

Industry

pharmaceutical manufacturing

Sectors

microbiota
biotherapeutics
Biotechnology
gut health
GutAlive
Intestinal Microbiota
Microbiology
human purified microbiota
microbiota storage
microbiota isolation
Clostridium difficile
microbiome
gut microbiota
Health Care
Intestinal disease
LBPs
anaerobes
Life Science
probiotics

Date founded

2016

Funding rounds raised

Total raised

$1.6M

from 1 investors over 1 rounds

M

Microviable Therapeutics SL raised $1.6M on April 19, 2022

Investors: Inmunomet Intolerancia y Disbiosis

FAQ